These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9440874)

  • 21. Current standards and future directions in immunotherapy: perspectives on challenges and opportunities for the allergist.
    Bernstein DI; Blaiss MS; Cox LS; Finegold I; Lanier BQ; Nelson HS; Wallace DV
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):422-5. PubMed ID: 22018613
    [No Abstract]   [Full Text] [Related]  

  • 22. The allergist and the intensivist: not such odd bedfellows.
    Pillay K; Fung SS; Cohn JR
    Ann Allergy Asthma Immunol; 2014 Feb; 112(2):94-6. PubMed ID: 24468246
    [No Abstract]   [Full Text] [Related]  

  • 23. [Insect venom allergies : Update 2016 for otorhinolaryngologists].
    Klimek L; Dippold N; Sperl A
    HNO; 2016 Dec; 64(12):927-942. PubMed ID: 27787580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Specific immunotherapy (desensitization)].
    Klimek L; Rasp G; Ebner C
    Wien Med Wochenschr; 1999; 149(14-15):393. PubMed ID: 10584281
    [No Abstract]   [Full Text] [Related]  

  • 25. Regulatory control and standardization of allergenic extracts. Clinical methods of evaluation of extracts.
    Norman PS
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):65-9. PubMed ID: 6625586
    [No Abstract]   [Full Text] [Related]  

  • 26. How to stop the allergy march.
    Lopes Dos Santos JM
    Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):39-40. PubMed ID: 17761107
    [No Abstract]   [Full Text] [Related]  

  • 27. Survey on immunotherapy practice patterns: dose, dose adjustments, and duration.
    Larenas-Linnemann DE; Gupta P; Mithani S; Ponda P
    Ann Allergy Asthma Immunol; 2012 May; 108(5):373-378.e3. PubMed ID: 22541411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotherapy coming of age: notable advances during the first hundred years.
    Nelson HS
    Expert Rev Clin Immunol; 2017 May; 13(5):389-392. PubMed ID: 28443797
    [No Abstract]   [Full Text] [Related]  

  • 29. Allergy: current crisis.
    Vaughan JH
    J Allergy; 1968 May; 41(5):241-5. PubMed ID: 4172261
    [No Abstract]   [Full Text] [Related]  

  • 30. [Desensitization therapy].
    Suomen Allergologi- ja Immunologiyhdistys ry:n asettama työryhmä
    Duodecim; 2002; 118(12):1302-9. PubMed ID: 12239822
    [No Abstract]   [Full Text] [Related]  

  • 31. Regulatory control and standardization of allergenic extracts. Leading motive: thesis and antithesis.
    Göing H
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):7-11. PubMed ID: 6625587
    [No Abstract]   [Full Text] [Related]  

  • 32. Some highlights of the first century of immunotherapy.
    Nelson HS
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):417-21. PubMed ID: 22018612
    [No Abstract]   [Full Text] [Related]  

  • 33. [Governmental batch sample testing of allergen products].
    Bartel D; Führer F; Vieths S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Mar; 55(3):358-62. PubMed ID: 22373849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. THE IMMUNOLOGY OF ALLERGY.
    BARLOW PP
    Calif Med; 1964 Aug; 101(2):90-4. PubMed ID: 14180503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allergen immunotherapy: a practice parameter. American Academy of Allergy, Asthma and Immunology. American College of Allergy, Asthma and Immunology.
    Joint Task Force on Practice Parameters
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1 Suppl 1):1-40. PubMed ID: 12542071
    [No Abstract]   [Full Text] [Related]  

  • 36. Regulatory control and standardization of allergenic extracts. The clinical trial protocol.
    Aas K
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):55-63. PubMed ID: 6354091
    [No Abstract]   [Full Text] [Related]  

  • 37. [Allergy to domestic and laboratory animals].
    Bousquet J; Guerin B; Michel FB
    Rev Mal Respir; 1986; 3(1):25-9. PubMed ID: 3715163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of mite growth culture phases on the biological standardization of allergenic extracts.
    Eraso E; Martínez J; García-Ortega P; Martínez A; Palacios R; Cisterna R; Guisantes JA
    J Investig Allergol Clin Immunol; 1998; 8(4):201-6. PubMed ID: 9777533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Specific treatments of allergic manifestations].
    Vervloet D; Charpin D
    Rev Prat; 1996 Apr; 46(8):985-90. PubMed ID: 8762236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification.
    van Ree R; Chapman MD; Ferreira F; Vieths S; Bryan D; Cromwell O; Villalba M; Durham SR; Becker WM; Aalbers M; André C; Barber D; Cistero Bahima A; Custovic A; Didierlaurent A; Dolman C; Dorpema JW; Di Felice G; Eberhardt F; Fernandez Caldas E; Fernandez Rivas M; Fiebig H; Focke M; Fötisch K; Gadermaier G; Das RG; Gonzalez Mancebo E; Himly M; Kinaciyan T; Knulst AC; Kroon AM; Lepp U; Marco FM; Mari A; Moingeon P; Monsalve R; Neubauer A; Notten S; Ooievaar-de Heer P; Pauli G; Pini C; Purohit A; Quiralte J; Rak S; Raulf-Heimsoth M; San Miguel Moncin MM; Simpson B; Tsay A; Vailes L; Wallner M; Weber B
    Allergy; 2008 Mar; 63(3):310-26. PubMed ID: 18269676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.